Main Article Content Keywords psoriasis, tuberculosis, biologic, PPD, IGRA, cost, screening Abstract Background: Current recommendations for biologic use in psoriasis recommend baseline TB screening with IGRA. Studies have found in low TB prevalence countries that TB conversion occurs at low rates in those utilizing biologic therapies. Objectives: To evaluate utilization and cost effectiveness of TB testing in patients with psoriasis being treated with biologics.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Steven
Contact Steven, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack